After this rapid appearance, the pigment is stable
In clinical practice, HCV genotype can be determined by various commercial kits, using direct sequence analysis of the 5' noncoding region (Trugene 5'NC HCV Genotyping Kit, Bayer HealthCare, Diagnostics Division, Tarrytown, New York) or reverse hybridization analysis using genotype-specific probes located in the 5' noncoding region (commercialized as INNO-LiPA HCV II, Innogenetics, Ghent, Belgium, or Versant HCV Genotyping Assay, Bayer HealthCare) [10-13 ]
PlexusDx's genetic and biomarker approach may help provide context on how your unique predispositions in peptide-response pathways could influence safety risk, supporting a more informed conversation with your healthcare provider
Long-term safety data limited